Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
10%
ALSO IN THNR
THNR
17
HOLDINGS
32%
ALSO IN XLV
SECTOR DRIFT (XLV minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.4% | 12.3% | 12.3% |
|
MERCK & CO. INC. | 5.3% | 6.0% | 5.3% |
|
ABBVIE INC | 7.2% | 5.0% | 5.0% |
|
AMGEN INC | 3.6% | 7.8% | 3.6% |
|
PFIZER INC | 2.8% | 5.3% | 2.8% |
XLV Overweight Relative to THNR
|
JOHNSON & JOHNSON | 10.7% |
|
UNITEDHEALTH GROUP INC | 4.7% |
|
ABBOTT LABORATORIES | 3.5% |
|
GILEAD SCIENCES INC | 3.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.2% |
|
INTUITIVE SURGICAL INC | 3.1% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
|
VERTEX PHARMACEUTICALS INC | 2.2% |
|
ABBVIE INC | 2.2% |
|
DANAHER CORP | 2.2% |
XLV Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -9.6% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -7.4% |
|
SHIONOGI & CO LTD | -6.2% |
|
REGENERON PHARMACEUTICALS | -5.4% |
 |
ASTRAZENECA PLC | -5.3% |
 |
ROCHE HOLDING LTD | -5.1% |
 |
INNOVENT BIOLOGICS, INC. | -4.7% |
|
AMGEN INC | -4.2% |
 |
CHINA PHARMACEUTICAL GROUP | -4.0% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.4% |